Orpha Swiss


Esmolol Hcl 100 Mg / 10 Ml Solution For Injection
 

Composition

A vial of 10 ml solution contains 100 mg esmolol hydrochloride. 1 ml aqueous solution contains 10 mg esmolol hydrochloride (10 mg / ml)

Pharmaceutical form

Solution for injection.
The solution is clear and colourless.

Therapeutic Indications

Esmolol HCl 100 mg / 10 ml is used for the short-term treatment of supraventricular tachycardia (except for pre-excitation syndromes), and for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable.
It is also indicated for tachycardia and hypertension during the perioperative phase and non-compensatory sinus tachycardia where, in the physicians judgment the rapid heart rate requires specific intervention.

Posology and method of administration

Esmolol HCl 100 mg / 10 ml solution for injection in a vial is a clear solution directly for intravenous use.

Special warnings and precautions for use

See SPC

Interaction with other pharmaceuticals

See SPC

Pregnancy and lactation

See SPC

Effects on abilities

See SPC

Overdose

See SPC

Pharmacological Properties

Pharmacotherapeutic group: Beta-blocking agents, selective
ATC code: C07AB09

Futher information's: See SPC

Excipients

See SPC

Shelf life

See SPC

Storage

15C to 25 C

Packaging

Pack of 5 vials